Security key
03836J201
Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)
CUSIP: 03836J201
Q2 2026 13F Holders as of 30 Jun 2026
- Security type / class
- Equity / Common stock, par value $0.001 per share
- Total 13F shares
- 16
- Total 13F value
- $13
- Share change
- 0
- SEC-reported price per share
- $0.81
- Number of holders
- 1
- Shares outstanding
- 9,144,889
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
1
Top holders
1
APRE full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q1 2026
Aprea Therapeutics, Inc. SEC filings
Aprea Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03836J201
Recent filing periods:
Ownership snapshot
Top reported holders of APRE - Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Private Equity Fun...
Disclosed value leader
Laurence W. Lytton
Comparable rows
15/15
Latest evidence
01 Apr 2026
13D/G
13F
Lead comparable stake: 10%
13D/G row: Soleus Private Equity Fund III, L.P.
Showing 1-6 of 15 holder rows.
Quick read
Soleus Private Equity Fund III, L.P. leads the comparable SEC ownership view at 10%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Private Equity Fund III, L.P.'s linked filing trail.
Comparable ownership
Top 5
Soleus Private Equity Fund III, L.P.
10%
Laurence W. Lytton
9.9%
Vestal Point Capital, LP
9.9%
Squadron Capital Management LLC
9.9%
Orin Hirschman
9.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Private Equity Fund III, L.P. |
13D/G
|
10%
|
—
1,271,080 shares
|
$0 | 01 Apr 2026 |
| Laurence W. Lytton |
13D/G
LYTTON LAURENCE W
|
9.9%
|
$913,662
681,837 shares
|
$0 | 13 Nov 2025 |
| Vestal Point Capital, LP |
13F
13D/G
Company
|
9.9%
from 13D/G
|
$267,015
350,000 shares
|
— | 31 Mar 2026 |
| Squadron Capital Management LLC |
13D/G
Squadron Master Fund LP
|
9.9%
|
—
1,271,081 shares
|
$0 | 30 Mar 2026 |
| Orin Hirschman |
13D/G
|
9.9%
|
—
1,186,294 shares
|
$0 | 31 Mar 2026 |
| Nantahala Capital Management, LLC |
13D/G
13F
Company
|
4.5%
|
$386,829
411,520 shares
|
$0 | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
16
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q1 2026 Across Filers
Q1 2026 holders
22
Q2 2026 holders
1
Holder diff
-21
| Investor | Q1 2026 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend